Trial Profile
A Multicenter, Randomized, Double-masked and Placebo-controlled Study Evaluating the Efficacy and Safety of SI-614 Ophthalmic Solution in Patients With Dry Eye
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 17 Nov 2014
Price :
$35
*
At a glance
- Drugs Cinhyaluronate sodium (Primary)
- Indications Dry eyes
- Focus Registrational; Therapeutic Use
- Sponsors Seikagaku Corporation
- 13 Nov 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 08 May 2014 New trial record